Investors

• Financials
  • Key Ratios
  • Financial Reports
  • Profit share proposal
  • Regarding repayment of capital
• Stock Exchange Releases
  • Order releases to your email
• Annual Report
• Strategy and Objectives
  • Vision & Mission
  • Objectives
  • Short Term Risks
  • Outlook for The Year
• Operating Environment
  • Diagnostics
• Share Information
  • Share Capital
  • Redemption Rights
  • Share Monitor
  • Share History
• Shareholders
  • Number Dispersion
  • Major Shareholders
  • Notifications on major holdings
  • Insider Register
  • Insider Regulations
• Corporate Governance
  • General Meeting
  • Articles of Association
  • Board of Directors
  • Board Meetings
  • President and CEO
  • Other Management
  • Remuneration
  • Internal Control and Risk Management
  • Auditors
  • Insider Regulations
  • Disclosure Policy
• Group Management
  • President and CEO
  • Board of Directors
  • Subsidiary Management
  • Management
  • Remuneration
• Shareholder Meetings
  • Proposal of the Board 11.4.2012
  • Minutes of the Annual General Meeting
• Fact sheet for investors

Operating Environment

Biohit’s operations largely center on areas outside Finland. International sales account for 83.4 per cent of net sales. In addition to Europe, the company’s main market area is Asia.

Diagnostics products are used in hospitals, healthcare centers and general practices. Consumers are a new customer group for Biohit.

In its main market areas, Biohit has subsidiary, partners and distributors.